Update on diagnosis and treatment of Kawasaki disease

2025, Volume 9, Issue 4: 270-272. doi: 10.3934/Allergy.2025020

Previous Article Next Article

Editorial

1.
Shaanxi Provincial Kawasaki Disease Research Center, Children's Hospital of Shaanxi Provincial People's Hospital, Proactive Medical Committee, World Artificial Consciousness Association, China
2.
The First Affiliated Hospital of Yangtze University, China

Received: 27 November 2025 Revised: 27 November 2025 Accepted: 27 November 2025 Published: 28 November 2025

Citation: Fuyong Jiao, Yan Pan. Update on diagnosis and treatment of Kawasaki disease[J]. AIMS Allergy and Immunology, 2025, 9(4): 270-272. doi: 10.3934/Allergy.2025020

Related Papers:

[1]	Nicholas H, Megan A, Richard J (2025) Update on diagnosis and management of Kawasaki disease: A scientific statement from the American heart association. J Cardiothorac Vasc Anesth 39: 1103-1105. https://doi.org/10.1053/j.jvca.2025.02.007
[2]	Jiao F, Pan Y, Du Z, et al. (2024) Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China. BMC Pediatr 24: 477. https://doi.org/10.1186/s12887-024-04961-2
[3]	Anurag RG, Ali Y (2025) An update on multi-system inflammatory syndrome in children. Curr Rheumatol Rep 27. https://doi.org/10.1007/s11926-025-01182-z
[4]	Yin QL, Liu YQ, Zhang HM (2025) Clinical advancements of biologic agents in the treatment of Kawasaki disease based on its pathogenesis. AIMS Allergy Immunol 9: 108-122. https://doi.org/10.3934/Allergy.2025008
[5]	Jiao F, Pan Y, Shah JN, et al. (2024) Challenges and management of bleeding in Kawasaki disease with aspirin treatment. AIMS Allergy Immunol 8: 324-332. https://doi.org/10.3934/Allergy.2024020
[6]	Friedman KG, Jone PN (2020) Update on the management of Kawasaki disease. Pediatr Clin N Am 67: 811-819. https://doi.org/10.1016/j.pcl.2020.06.002

Reader Comments

Your name:*

Email:*
© 2025 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)